vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and OP Bancorp (OPBK). Click either name above to swap in a different company.

OP Bancorp is the larger business by last-quarter revenue ($24.3M vs $14.7M, roughly 1.6× IRIDEX CORP). On growth, OP Bancorp posted the faster year-over-year revenue change (13.7% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs 11.4%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

OP Bancorp is the bank holding company for Open Bank, a community-oriented commercial bank headquartered in California, United States. It provides a full range of banking solutions including deposit accounts, commercial real estate loans, small business financing, and consumer lending products, primarily catering to small and medium-sized enterprises, local immigrant communities, and retail clients across Southern California.

IRIX vs OPBK — Head-to-Head

Bigger by revenue
OPBK
OPBK
1.6× larger
OPBK
$24.3M
$14.7M
IRIX
Growing faster (revenue YoY)
OPBK
OPBK
+83.5% gap
OPBK
13.7%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
11.4%
OPBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRIX
IRIX
OPBK
OPBK
Revenue
$14.7M
$24.3M
Net Profit
Gross Margin
37.2%
Operating Margin
39.2%
Net Margin
Revenue YoY
-69.7%
13.7%
Net Profit YoY
EPS (diluted)
$0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
OPBK
OPBK
Q4 25
$14.7M
$24.3M
Q3 25
$12.5M
$24.5M
Q2 25
$13.6M
$23.7M
Q1 25
$11.9M
$22.2M
Q4 24
$12.7M
$21.3M
Q3 24
$11.6M
$20.7M
Q2 24
$12.6M
$20.4M
Q1 24
$11.8M
$19.6M
Net Profit
IRIX
IRIX
OPBK
OPBK
Q4 25
Q3 25
$-1.6M
$6.7M
Q2 25
$-994.0K
$6.3M
Q1 25
$-1.7M
$5.6M
Q4 24
$-834.0K
Q3 24
$-1.9M
$5.4M
Q2 24
$-2.7M
$5.4M
Q1 24
$-3.5M
$5.2M
Gross Margin
IRIX
IRIX
OPBK
OPBK
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
OPBK
OPBK
Q4 25
39.2%
Q3 25
-11.3%
39.5%
Q2 25
-6.9%
35.7%
Q1 25
-1.7%
34.6%
Q4 24
-3.9%
31.2%
Q3 24
-16.1%
36.5%
Q2 24
-20.9%
37.2%
Q1 24
-28.0%
37.1%
Net Margin
IRIX
IRIX
OPBK
OPBK
Q4 25
Q3 25
-12.6%
27.4%
Q2 25
-7.3%
26.7%
Q1 25
-14.2%
25.0%
Q4 24
-6.6%
Q3 24
-16.7%
26.2%
Q2 24
-21.2%
26.7%
Q1 24
-29.5%
26.7%
EPS (diluted)
IRIX
IRIX
OPBK
OPBK
Q4 25
$0.48
Q3 25
$-0.09
$0.45
Q2 25
$-0.06
$0.42
Q1 25
$-0.10
$0.37
Q4 24
$-0.05
$0.33
Q3 24
$-0.12
$0.36
Q2 24
$-0.16
$0.36
Q1 24
$-0.21
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
OPBK
OPBK
Cash + ST InvestmentsLiquidity on hand
$6.0M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$227.9M
Total Assets
$29.2M
$2.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
OPBK
OPBK
Q4 25
$6.0M
$167.3M
Q3 25
$5.6M
$166.7M
Q2 25
$6.8M
$205.4M
Q1 25
$7.2M
$198.9M
Q4 24
$2.4M
$134.9M
Q3 24
$3.9M
$166.8M
Q2 24
$4.1M
$127.7M
Q1 24
$5.4M
$139.2M
Total Debt
IRIX
IRIX
OPBK
OPBK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
OPBK
OPBK
Q4 25
$227.9M
Q3 25
$4.7M
$221.5M
Q2 25
$6.1M
$213.7M
Q1 25
$852.0K
$210.1M
Q4 24
$2.1M
$205.0M
Q3 24
$2.6M
$203.6M
Q2 24
$4.2M
$195.9M
Q1 24
$6.5M
$194.7M
Total Assets
IRIX
IRIX
OPBK
OPBK
Q4 25
$29.2M
$2.7B
Q3 25
$28.4M
$2.6B
Q2 25
$31.6M
$2.6B
Q1 25
$34.2M
$2.5B
Q4 24
$29.1M
$2.4B
Q3 24
$30.2M
$2.4B
Q2 24
$31.2M
$2.3B
Q1 24
$34.1M
$2.2B
Debt / Equity
IRIX
IRIX
OPBK
OPBK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
OPBK
OPBK
Operating Cash FlowLast quarter
$26.2M
Free Cash FlowOCF − Capex
$23.4M
FCF MarginFCF / Revenue
96.2%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$43.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
OPBK
OPBK
Q4 25
$26.2M
Q3 25
$-1.2M
$23.9M
Q2 25
$-397.0K
$-7.0M
Q1 25
$-1.1M
$5.6M
Q4 24
$-1.2M
$31.2M
Q3 24
$-3.1M
$13.3M
Q2 24
$-1.3M
$15.8M
Q1 24
$-1.6M
$-3.2M
Free Cash Flow
IRIX
IRIX
OPBK
OPBK
Q4 25
$23.4M
Q3 25
$-1.2M
$23.4M
Q2 25
$-410.0K
$-7.7M
Q1 25
$-1.2M
$4.2M
Q4 24
$-1.2M
$29.7M
Q3 24
$-3.1M
$12.8M
Q2 24
$15.7M
Q1 24
$-1.7M
$-3.2M
FCF Margin
IRIX
IRIX
OPBK
OPBK
Q4 25
96.2%
Q3 25
-9.4%
95.6%
Q2 25
-3.0%
-32.5%
Q1 25
-9.8%
19.0%
Q4 24
-9.8%
139.0%
Q3 24
-26.5%
61.5%
Q2 24
77.0%
Q1 24
-14.0%
-16.6%
Capex Intensity
IRIX
IRIX
OPBK
OPBK
Q4 25
11.5%
Q3 25
0.1%
2.3%
Q2 25
0.1%
3.0%
Q1 25
0.1%
6.4%
Q4 24
0.1%
7.3%
Q3 24
0.0%
2.8%
Q2 24
0.0%
0.4%
Q1 24
0.0%
0.5%
Cash Conversion
IRIX
IRIX
OPBK
OPBK
Q4 25
Q3 25
3.57×
Q2 25
-1.10×
Q1 25
1.02×
Q4 24
Q3 24
2.45×
Q2 24
2.90×
Q1 24
-0.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons